Pramipexole Tablets 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is inadequate, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medication should not be administered to patients with allergies to the active ingredient or other components. Additionally, it should not be used if the patient is currently taking or has recently discontinued other MAO inhibitors, certain analgesics, or antidepressants. It should not be administered to patients with moderate or severe liver dysfunction, and caution is required in patients with mild liver impairment. Various side effects such as infections, headaches, dizziness, depression, hallucinations, and skin rashes may occur; therefore, if any unusual symptoms appear, immediate consultation with a healthcare provider is necessary. Particularly in Parkinson's disease patients, there may be occurrences of movement disorders, hypotension, or impulse control disorders; regular monitoring is essential. This medication may affect driving or machine operation, so activities should be avoided if drowsiness or sudden sleep symptoms occur. Moreover, severe side effects may arise when combined with certain medications; if other medications are being taken, it must be reported to the healthcare provider. Caution should be exercised regarding this medication during pregnancy or breastfeeding, and safety and efficacy have not been established for children under 18 years of age. In case of overdose, severe cardiovascular or neurological symptoms may occur, thus immediate visit to a medical institution for appropriate treatment is required. Lastly, this medication should be stored in a cool place out of reach of children, and transferring it to another container should be avoided.

• Influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication must be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to store the medication at room temperature between 1 to 25 degrees Celsius.

Appearance

White or almost white, flat, round tablets with edges

Package unit

30 tablets/bottle, 100 tablets/bottle